Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial

Autor: Irene Pericot-Valverde, Moonseong Heo, Matthew J. Akiyama, Brianna L. Norton, Linda Agyemang, Jiajing Niu, Alain H. Litwin

Publikováno v: BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)

Abstract Background Cigarette smoking has emerged as a leading cause of mortality among people with hepatitis C virus (HCV). People who inject drugs (PWID) represent the largest group of adults infected with HCV in the US. However, cigarette smoking

Externí odkaz: https://doaj.org/article/b0009318ba7f4d9d87e8f177c727f352

Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

Autor: Qinglu Cheng, Evan B. Cunningham, Sophy Shih, Janaki Amin, Julie Bruneau, Adelina A. Artenie, Jeff Powis, Alain H. Litwin, Curtis Cooper, Olav Dalgard, Margaret Hellard, Philip Bruggmann, Philippa Marks, Karine Lacombe, Catherine Stedman, Phillip Read, Behzad Hajarizadeh, Adrian J. Dunlop, Brian Conway, Jordan J. Feld, Gregory J. Dore, Jason Grebely, Gregory Dore, Sione Crawford, Tracy Swan, Jude Byrne, Melanie Lacalamita. Coordinating Centre—Amanda Erratt, Evan Cunningham, Pip Marks, Ineke Shaw, Sharmila Siriragavan, Sophie Quiene, Kathy Petoumenos, Patrick Schmid, Erika Castro, Alberto Moriggia, Jean-Pierre Daulouede, Christopher Fraser, Jordan Feld, Ed Gane, Gail Matthews, Adrian Dunlop, Ian Kronborg, David Shaw, Alain Litwin, Brianna Norton, Maria Christine Thurnheer, Martin Weltman, Philip Read, John Dillon, Simone Kessler, Cornelia Knapp, Lorenza Oprandi, Paola Messina, Marzia Pantic, Manuela Le Cam, Cecilia Maitre, Jessica Andreassen, Ingunn Melkeraaen, Merete Moen Tollefsen, Hannah Pagarigan, Rozalyn Milne, Kate Mason, Diana Kaznowski, Lily Zou, Rachel Bouchard, Barbara Kotsoros, Miriam Muir, Jessica Milloy, Victoria Oliver, Tracy Noonan, Alison Sevehon, Susan Hazelwood, Michelle Hall, Michelle Hagenauer, Rachel Liddle, Catherine Ferguson, Linda Agyemang, Hiral Patel, Irene Soloway, Orlando Cerocchi, Melanie Lacalamita, Vincenzo Fragomeli, Rosie Gilliver, Rebecca Lothian, Shirley Cleary, Linda Johnston, Sarah Middleton, Ronald D’Amico, Barbara McGovern, Jonathan Anderson, Ze Zhong, Fiona Keane, Fernando Tatsch, Diana Brainard, John McHutchison

Publikováno v: Value in Health. 26:883-892

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ee5950dc9b00953ac5284758ffc480d
https://doi.org/10.1016/j.jval.2022.12.016

Hepatitis C Virus Direct-Acting Antiviral Treatment Adherence Patterns and Sustained Viral Response Among People Who Inject Drugs Treated in Opioid Agonist Therapy Programs

Autor: Alain H. Litwin, Brianna L. Norton, Irene Pericot-Valverde, Lior Rennert, Matthew J. Akiyama, Mirinda Ann Gormley, Linda Agyemang, Moonseong Heo, Julia H. Arnsten

Publikováno v: Clin Infect Dis

Background Adequate medication adherence is critical for achieving sustained viral response (SVR) of hepatitis C virus (HCV) among people who inject drugs (PWID). However, it is less known which patterns of direct-acting antiviral (DAA) treatment adh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2b9ed7903c655f528507693a776732
https://doi.org/10.1093/cid/ciab334

Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens

Autor: Yolanda Lie, Matthew J. Akiyama, Lindsey Riback, Jacqueline D. Reeves, Alain H. Litwin, Brianna L. Norton, Linda Agyemang, Julia H. Arnsten

Publikováno v: Open Forum Infectious Diseases

BackgroundResistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) can contribute to virologic failure and limit retreatment options. People who inject drugs (PWID) are at highest risk for transmission of resistant virus. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb386b6cc630c030e7925f4bae3a30e1
https://doi.org/10.1093/ofid/ofab474

Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial

Autor: Matthew J. Akiyama, Alain H. Litwin, Linda Agyemang, Jiajing Niu, Brianna L. Norton, Irene Pericot-Valverde, Moonseong Heo

Publikováno v: BMC Infectious Diseases
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)

Background Cigarette smoking has emerged as a leading cause of mortality among people with hepatitis C virus (HCV). People who inject drugs (PWID) represent the largest group of adults infected with HCV in the US. However, cigarette smoking remains v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01139e6b177c4f844f4bfdbd9f0aa5f6
http://europepmc.org/articles/PMC7718688